Avacta Group PLC
F:RTQ1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Avacta Group PLC
F:RTQ1
|
UK |
|
G
|
GlaxoSmithKline PLC
XHAM:GS7
|
UK |
|
L
|
L'Oreal SA
F:LOR
|
FR |
|
SB Financial Group Inc
F:9KH
|
US |
|
B
|
Biotest AG
XHAM:BIO3
|
DE |
|
Precigen Inc
NASDAQ:PGEN
|
US |
|
Selvaag Bolig ASA
F:S2B
|
NO |
|
B
|
Biotest AG
DUS:BIO
|
DE |
Wall St Price Targets
RTQ1 Price Targets Summary
Avacta Group PLC
According to Wall Street analysts, the average 1-year price target for
RTQ1 is 0.676 EUR with a low forecast of 0.558 EUR and a high forecast of 0.812 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RTQ1's stock price target?
Price Target
0.676
EUR
According to Wall Street analysts, the average 1-year price target for
RTQ1 is 0.676 EUR with a low forecast of 0.558 EUR and a high forecast of 0.812 EUR.
What is the Revenue forecast for Avacta Group PLC?
Projected CAGR
15%
Over the last 4 years, the compound annual growth rate for Revenue has been -52%. The projected CAGR for the next 4 years is 15%.